170 related articles for article (PubMed ID: 31787235)
1. miR-150 inhibitor ameliorates adriamycin-induced focal segmental glomerulosclerosis.
Qi H; Fu J; Luan J; Jiao C; Cui X; Cao X; Zhang Y; Wang Y; Kopp JB; Pi J; Zhou H
Biochem Biophys Res Commun; 2020 Feb; 522(3):618-625. PubMed ID: 31787235
[TBL] [Abstract][Full Text] [Related]
2. LNA-anti-miR-150 ameliorated kidney injury of lupus nephritis by inhibiting renal fibrosis and macrophage infiltration.
Luan J; Fu J; Chen C; Jiao C; Kong W; Zhang Y; Chang Q; Wang Y; Li D; Illei GG; Kopp JB; Pi J; Zhou H
Arthritis Res Ther; 2019 Dec; 21(1):276. PubMed ID: 31829247
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-155-5p Aggravates Adriamycin-Induced Focal Segmental Glomerulosclerosis through Targeting Nrf2.
Liu G; He L; Yang X; Tang L; Shi W; She J; Wei J
Nephron; 2023; 147(2):108-119. PubMed ID: 35728579
[TBL] [Abstract][Full Text] [Related]
4. CircZNF609 is involved in the pathogenesis of focal segmental glomerulosclerosis by sponging miR-615-5p.
Cui X; Fu J; Luan J; Qi H; Jiao C; Ran M; Wang D; Hao X; Zhang Y; Kopp JB; Pi J; Zhou H
Biochem Biophys Res Commun; 2020 Oct; 531(3):341-349. PubMed ID: 32800553
[TBL] [Abstract][Full Text] [Related]
5. C-C chemokine receptor type 2 mediates glomerular injury and interstitial fibrosis in focal segmental glomerulosclerosis.
Wilkening A; Krappe J; Mühe AM; Lindenmeyer MT; Eltrich N; Luckow B; Vielhauer V
Nephrol Dial Transplant; 2020 Feb; 35(2):227-239. PubMed ID: 30597038
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-206 and its down-regulation of Wilms'Tumor-1 dictate podocyte health in adriamycin-induced nephropathy.
Guo N; Guo J; Su D
Ren Fail; 2016 Jul; 38(6):989-95. PubMed ID: 27056206
[TBL] [Abstract][Full Text] [Related]
7. The long noncoding RNA LOC105374325 causes podocyte injury in individuals with focal segmental glomerulosclerosis.
Hu S; Han R; Shi J; Zhu X; Qin W; Zeng C; Bao H; Liu Z
J Biol Chem; 2018 Dec; 293(52):20227-20239. PubMed ID: 30389788
[TBL] [Abstract][Full Text] [Related]
8. CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome.
Vielhauer V; Berning E; Eis V; Kretzler M; Segerer S; Strutz F; Horuk R; Gröne HJ; Schlöndorff D; Anders HJ
Kidney Int; 2004 Dec; 66(6):2264-78. PubMed ID: 15569315
[TBL] [Abstract][Full Text] [Related]
9. Salidroside Attenuates Adriamycin-Induced Focal Segmental Glomerulosclerosis by Inhibiting the Hypoxia-Inducible Factor-1α Expression Through Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway.
Liu G; He L
Nephron; 2019; 142(3):243-252. PubMed ID: 30840958
[TBL] [Abstract][Full Text] [Related]
10. Astaxanthin attenuates adriamycin-induced focal segmental glomerulosclerosis.
Liu G; Shi Y; Peng X; Liu H; Peng Y; He L
Pharmacology; 2015; 95(3-4):193-200. PubMed ID: 25924598
[TBL] [Abstract][Full Text] [Related]
11. LNA-anti-miR-150 alleviates renal interstitial fibrosis by reducing pro-inflammatory M1/M2 macrophage polarization.
Hao X; Luan J; Jiao C; Ma C; Feng Z; Zhu L; Zhang Y; Fu J; Lai E; Zhang B; Wang Y; Kopp JB; Pi J; Zhou H
Front Immunol; 2022; 13():913007. PubMed ID: 35990680
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol Attenuates Adriamycin-Induced Focal Segmental Glomerulosclerosis through C3aR/C5aR- Sphingosine Kinase 1 Pathway.
Liu G; Wang Q; Shi Y; Peng X; Liu H; Peng Y; He L
Pharmacology; 2017; 100(5-6):253-260. PubMed ID: 28797008
[TBL] [Abstract][Full Text] [Related]
13. Role of autophagy and evaluation the effects of microRNAs 214, 132, 34c and prorenin receptor in a rat model of focal segmental glomerulosclerosis.
Yildirim D; Bender O; Karagoz ZF; Helvacioglu F; Bilgic MA; Akcay A; Ruzgaresen NB
Life Sci; 2021 Sep; 280():119671. PubMed ID: 34087284
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow mesenchymal stem cells attenuate the progression of focal segmental glomerulosclerosis in rat models.
Yang RC; Zhu XL; Wang J; Wan F; Zhang HQ; Lin Y; Tang XL; Zhu B
BMC Nephrol; 2018 Nov; 19(1):335. PubMed ID: 30466397
[TBL] [Abstract][Full Text] [Related]
15. Role of Protease-Activated Receptor 2 in Regulating Focal Segmental Glomerulosclerosis.
Wang Y; He Y; Wang M; Lv P; Liu J; Wang J
Cell Physiol Biochem; 2017; 41(3):1147-1155. PubMed ID: 28245472
[TBL] [Abstract][Full Text] [Related]
16. Osteopontin as an injury marker expressing in epithelial hyperplasia lesions helpful in prognosis of focal segmental glomerulosclerosis.
Shui HA; Ka SM; Yang SM; Lin YF; Lo YF; Chen A
Transl Res; 2007 Oct; 150(4):216-22. PubMed ID: 17900509
[TBL] [Abstract][Full Text] [Related]
17. Bradykinin receptor 1 activation exacerbates experimental focal and segmental glomerulosclerosis.
Pereira RL; Buscariollo BN; Corrêa-Costa M; Semedo P; Oliveira CD; Reis VO; Maquigussa E; Araújo RC; Braga TT; Soares MF; Moura IC; Malheiros DM; Filho AP; Keller AC; Câmara NO
Kidney Int; 2011 Jun; 79(11):1217-27. PubMed ID: 21412216
[TBL] [Abstract][Full Text] [Related]
18. New Anti-Nephrin Antibody Mediated Podocyte Injury Model Using a C57BL/6 Mouse Strain.
Takeuchi K; Naito S; Kawashima N; Ishigaki N; Sano T; Kamata K; Takeuchi Y
Nephron; 2018; 138(1):71-87. PubMed ID: 28965116
[TBL] [Abstract][Full Text] [Related]
19. Plasma microRNA-186 and proteinuria in focal segmental glomerulosclerosis.
Zhang C; Zhang W; Chen HM; Liu C; Wu J; Shi S; Liu ZH
Am J Kidney Dis; 2015 Feb; 65(2):223-32. PubMed ID: 25218681
[TBL] [Abstract][Full Text] [Related]
20. Beneficial Effects of Systemically Administered Human Muse Cells in Adriamycin Nephropathy.
Uchida N; Kushida Y; Kitada M; Wakao S; Kumagai N; Kuroda Y; Kondo Y; Hirohara Y; Kure S; Chazenbalk G; Dezawa M
J Am Soc Nephrol; 2017 Oct; 28(10):2946-2960. PubMed ID: 28674043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
